Not medical advice. I am a software engineer, not a physician. This page documents my own protocol and the research I read while building it. Talk to a qualified clinician before changing your supplementation, diet or any treatment. Lab reference ranges quoted here vary by laboratory and by individual.
Affiliate disclosure: the iHerb links on this page carry a referral code and pay me a commission if you buy. It does not change your price, and I do not link anything I do not use myself.
Sinetrol is a patented polyphenol extract derived from a specific combination of citrus fruits: blood orange (Citrus sinensis), grapefruit (Citrus paradisi), sweet orange, and guarana (Paullinia cupana). Developed by Fytexia, a French biotech company, Sinetrol was designed to target stored body fat through a well-defined biochemical mechanism rather than through stimulant-driven thermogenesis. Unlike caffeine-heavy fat burners that work primarily by raising heart rate and causing jitteriness, Sinetrol acts at the cellular level to unlock fat from adipocytes (fat cells), with clinical trials specifically demonstrating reduction in abdominal fat — the most metabolically dangerous fat depot linked to cardiovascular disease, insulin resistance, and chronic inflammation.
Sinetrol's mechanism centers on the inhibition of phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP (cAMP) inside cells. cAMP is a critical second messenger that activates protein kinase A (PKA), which in turn phosphorylates and activates hormone-sensitive lipase (HSL) — the enzyme that directly breaks triglycerides stored in fat cells into free fatty acids and glycerol for use as energy.
Here is the cascade: Sinetrol polyphenols inhibit PDE → cAMP levels rise → PKA is activated → HSL is phosphorylated → stored triglycerides are hydrolyzed → free fatty acids are released into the bloodstream for oxidation. This is the same lipolytic pathway activated by exercise and fasting, but Sinetrol provides additional sustained stimulation of the pathway between meals and during rest.
The citrus polyphenols in Sinetrol (primarily naringin from grapefruit, hesperidin from orange, and caffeine from guarana) work synergistically. The polyphenols provide the PDE inhibition while the modest caffeine content (much lower than typical fat burners) provides complementary catecholamine support. Clinical data shows that Sinetrol preferentially targets visceral and subcutaneous abdominal fat, likely because abdominal adipocytes have higher concentrations of beta-adrenergic receptors that are more responsive to cAMP-mediated lipolysis.
Brand: Irwin Naturals — Stored Fat Belly Burner (100 liquid soft-gels)
| Meal | Dose | Notes |
|---|---|---|
| Breakfast | 3 liquid soft-gels | Take with food for optimal absorption of lipophilic compounds |
| Lunch | 3 liquid soft-gels | Take with food for optimal absorption of lipophilic compounds |
Total daily dose: 6 liquid soft-gels (split across two meals). The split dosing maintains elevated cAMP levels throughout the active hours when fat oxidation is highest. Avoid evening dosing due to the guarana caffeine content. See the full timing context in the Supplement Stack.
A randomized, double-blind, placebo-controlled trial evaluated the effects of Sinetrol supplementation in overweight subjects over 12 weeks. The Sinetrol group experienced significant reductions in body fat percentage, waist circumference, hip circumference, and abdominal fat compared to placebo. Specifically, the treatment group lost an average of 5.53% body fat compared to 1.20% in the control group. Waist circumference decreased by 5.71 cm in the Sinetrol group versus 1.56 cm in controls. No significant adverse effects were reported. PMID: 24462626
A follow-up clinical study specifically measured the effect of Sinetrol on abdominal adiposity using DEXA scanning. Results confirmed that the citrus polyphenol blend preferentially reduced abdominal fat mass compared to peripheral fat depots. Participants in the Sinetrol group showed significant decreases in waist-to-hip ratio and visceral fat area, with improvements in blood lipid markers including triglycerides and the total cholesterol/HDL ratio. The preferential abdominal fat reduction is clinically significant because visceral fat is the strongest independent predictor of metabolic syndrome. PMID: 26373323
A broader review of citrus polyphenols confirmed the multi-target effects of these compounds on lipid metabolism. Beyond PDE inhibition, citrus flavanones (naringin, hesperidin) activate AMPK (AMP-activated protein kinase), reduce hepatic lipogenesis, improve insulin sensitivity, and exert anti-inflammatory effects that reduce the chronic low-grade inflammation associated with obesity. These pleiotropic mechanisms explain why Sinetrol improves multiple metabolic markers simultaneously rather than only affecting body fat. PMID: 28722412
Since Sinetrol affects lipid metabolism and fat mobilization, monitoring the lipid panel tracks whether the lipolytic and metabolic benefits observed in clinical trials are being replicated in your individual case.
| Test | Why Monitor | Link |
|---|---|---|
| Lipid Panel (Total Cholesterol, LDL, HDL, Triglycerides) | Sinetrol improves triglycerides and total cholesterol/HDL ratio; track quarterly to confirm lipid improvements alongside fat loss | Lab Tests |
Irwin Naturals — Stored Fat Belly Burner (100 liquid soft-gels)
Price: $69.84
Buy on iHerb →
A 2025 randomized, double-blind, parallel trial published in the International Journal of Food Sciences and Nutrition found that 16 weeks of Sinetrol® XPur supplementation produced a 1.98% decrease in total fat percentage compared to placebo, with the notable distinction that lean mass actually increased despite fat mass reduction. A separate 2024 dose-response clinical trial found that Sinetrol® XPur improved HDL, HbA1c, and leptin levels while reducing LDL in a time-dependent manner, with higher dosage (1,800 mg/day) trending more effective for weight loss than 900 mg/day. The mechanism has been further characterized: Sinetrol® promotes adipose beiging (conversion of white fat to metabolically active beige fat), increasing energy expenditure through PDE-3 inhibition and elevated cAMP-driven lipolysis. No adverse events linked to Sinetrol® supplementation have been recorded across all studies from 2008–2025.